Comparison of Estimated LDL Cholesterol Equations with Direct Measurement in Patients with Angiographically Confirmed Coronary Artery Disease
- PMID: 36286294
- PMCID: PMC9604394
- DOI: 10.3390/jcdd9100342
Comparison of Estimated LDL Cholesterol Equations with Direct Measurement in Patients with Angiographically Confirmed Coronary Artery Disease
Abstract
Background and aims: Our goals in the study were to (1) quantify the discordance in LDL-C levels between equations (the Friedewald, Sampson, and Martin/Hopkins equations) and compare them with direct LDL-C (dLDL-C); and (2) explore the proportion of misclassified patients by calculated LDL-C using these three different equations. Methods: A total of 30,349 consecutive patients with angiographically confirmed coronary artery disease (CAD) were prospectively enrolled. Concordance was defined as if the LDL-C was <1.8 mmol/L with each pairwise comparison of LDL-C equations. Estimated LDL-C that fell into the same category as dLDL-C at the following levels: <1.4, 1.4 to 1.7, 1.8 to 2.5, 2.6 to 2.9, and ≥3.0 mmol/L was considered to have been correctly categorized. Results: The concordance was 96.3% (Sampson vs. Martin/Hopkins), 95.0% (Friedewald vs. Sampson), and 91.4% (Friedewald vs. Martin/Hopkins), respectively. This proportion fell to 82.4% in those with hypertriglyceridemia (TG ≥ 1.7 mmol/L). With an accurate classification rate of 73.6%, the Martin/Hopkins equation outperformed the Sampson equation (69.5%) and the Friedewald equation (59.3%) by a wide margin. Conclusions: Comparing it to the validated Martin/Hopkins equation, the Friedewald equation produced the lowest levels of LDL-C, followed by the Sampson equation. In the classification of LDL-C, the Martin/Hopkins equation has also been shown to be more accurate. There is a significant difference between the equations and the direct measurement method, which may lead to overtreatment or undertreatment.
Keywords: LDL-C.
Conflict of interest statement
Authors state no conflict of interest.
Figures




Similar articles
-
Comparison of Methods to Estimate Low-Density Lipoprotein Cholesterol in Patients With High Triglyceride Levels.JAMA Netw Open. 2021 Oct 1;4(10):e2128817. doi: 10.1001/jamanetworkopen.2021.28817. JAMA Netw Open. 2021. PMID: 34709388 Free PMC article.
-
Discordance Between Standard Equations for Determination of LDL Cholesterol in Patients With Atherosclerosis.J Am Coll Cardiol. 2022 Feb 15;79(6):530-541. doi: 10.1016/j.jacc.2021.11.042. J Am Coll Cardiol. 2022. PMID: 35144744
-
Correlation of extended Martin/Hopkins equation with a direct homogeneous assay in assessing low-density lipoprotein cholesterol in patients with hypertriglyceridemia.J Clin Lab Anal. 2023 Sep;37(17-18):e24963. doi: 10.1002/jcla.24963. Epub 2023 Sep 7. J Clin Lab Anal. 2023. PMID: 37679962 Free PMC article.
-
Accuracy of 23 Equations for Estimating LDL Cholesterol in a Clinical Laboratory Database of 5,051,467 Patients.Glob Heart. 2023 Jun 19;18(1):36. doi: 10.5334/gh.1214. eCollection 2023. Glob Heart. 2023. PMID: 37361322 Free PMC article.
-
Best practice for LDL-cholesterol: when and how to calculate.J Clin Pathol. 2023 Mar;76(3):145-152. doi: 10.1136/jcp-2022-208480. Epub 2023 Jan 17. J Clin Pathol. 2023. PMID: 36650044 Review.
Cited by
-
Assessing the Practical Differences in LDL-C Estimates Calculated by Friedewald, Martin/Hopkins, or NIH Equation 2: An Observation Cross-Sectional Study.J Lipid Atheroscler. 2023 Sep;12(3):252-266. doi: 10.12997/jla.2023.12.3.252. Epub 2023 Jun 20. J Lipid Atheroscler. 2023. PMID: 37800109 Free PMC article.
-
The Roles of Coronary Computed Tomography Angiography in Characterizing Coronary Plaque: Screening, Treatment, and Prevention.J Cardiovasc Dev Dis. 2023 Jan 24;10(2):43. doi: 10.3390/jcdd10020043. J Cardiovasc Dev Dis. 2023. PMID: 36826539 Free PMC article.
References
-
- Mach F., Baigent C., Catapano A.L., Koskinas K.C., Casula M., Badimon L., Chapman M.J., De Backer G.G., Delgado V., Ference B.A., et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Eur. Heart J. 2020;41:111–188. doi: 10.1093/eurheartj/ehz455. - DOI - PubMed
-
- Grundy S.M., Stone N.J., Bailey A.L., Beam C., Birtcher K.K., Blumenthal R.S., Braun L.T., de Ferranti S., Faiella-Tommasino J., Forman D.E., et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J. Am. Coll. Cardiol. 2019;73:e285–e350. doi: 10.1016/j.jacc.2018.11.003. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous